The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics. According to Cytiva’s 2023 Global Biopharma Resilience Index, the manufacturing of biologics in India is likely to increase over the next three years. Cytiva’s manufacturing facility in […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma Solutions, a division of Twist Bioscience, will leverage its Library of Libraries to […]
Congenica platform to continue providing tertiary analysis for Whole Genome Sequencing Cambridge, United Kingdom – Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, today announces a two-year extension to their contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in […]
Getinge has today completed the previously announced acquisition of 100% of the shares in High Purity New England, Inc. On May 31, 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. All conditions for the transaction and […]
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization Cambridge, UK – EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announced its first placement of a DNA synthesis development platform for evaluation at Imperial College […]
REDWOOD CITY, CA – Synthego, a leading provider of genome engineering solutions, has announced the launch of its IND-enabling (INDe) gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline. This innovative offering empowers researchers with high-quality gRNAs designed specifically for GLP-regulated preclinical and IND-enabling studies, incorporating comprehensive IND-compliant materials and documentation […]
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach with substantial cross-selling opportunities and complementary offerings Generates estimated $80 million of annual cost synergies by 2026 and enhanced combined path to profitability1 […]
Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models. (Gothenburg, Sweden) Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of […]
Fremont, California – SeqMatic, a leading provider of next-generation sequencing (NGS) and omics services, is proud to announce that it has received Visium Spatial Gene Expression and Visium Spatial Gene Expression for FFPE Certifications from 10x Genomics. These certifications further demonstrate SeqMatic’s commitment to delivering efficient and professional solutions to its customers with single-cell and […]
DALLAS – Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome™ platform, enabling understanding of cellular diversity and disease mechanisms on a much more granular level. By unlocking single-cell sequencing data through efficient and powerful analysis, g.nome can now help researchers better understand cellular heterogeneity and gene expression. “Single-cell RNA-seq is becoming more […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
